These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 191882
1. [Alcohol-dependent hyperlipoproteinemias (type IV hyperlipoproteinemia)]. Lacatîş D. Rev Med Chir Soc Med Nat Iasi; 1976; 80(3):339-46. PubMed ID: 191882 [No Abstract] [Full Text] [Related]
6. Pathogenesis of alcoholic hypertriglyceridemia and hypercholesterolemia. Baraona E, Savolainen M, Karsenty C, Leo MA, Lieber CS. Trans Assoc Am Physicians; 1983; 96():306-15. PubMed ID: 6687299 [No Abstract] [Full Text] [Related]
7. [Hyperlipoproteinemias and their skin manifestations]. Zabel R. Padiatr Grenzgeb; 1974; 13(2-3):99-107. PubMed ID: 4369584 [No Abstract] [Full Text] [Related]
14. [Therapy of hyperlipoproteinemia type II with Xantinol-nicotinate (author's transl)]. Haacke H, Parwaresch MR, Mäder C. Med Klin; 1977 Jul 08; 72(27):1183-7. PubMed ID: 196168 [Abstract] [Full Text] [Related]
15. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices]. Herrmann W, Reuter W. Z Gesamte Inn Med; 1982 Dec 15; 37(24):830-3. PubMed ID: 6963524 [No Abstract] [Full Text] [Related]
16. [Type-V-hyperlipoproteinemia]. Heckers H, Oehler G. Med Welt; 1975 Sep 26; 26(39):1766-74. PubMed ID: 170491 [No Abstract] [Full Text] [Related]
19. [Classification of hyperlipoproteinemia. II. Distribution principle of hyperlipoproteinemias according to Fredrickson et al. correlated with clinical dermatological possibilities]. Zabel R. Dermatol Monatsschr; 1973 Dec 26; 159(12):1137-43. PubMed ID: 4366868 [No Abstract] [Full Text] [Related]
20. [Sulfinpyrazone and lipoproteins: absence of effects on serum lipids in hyperlipoproteinemias of types II and IV]. Sommariva D, Scotti L, Baroni L, Beggi P, Fasoli A. Clin Ter; 1980 Mar 31; 92(6):649-55. PubMed ID: 7460493 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]